Leveraging 50 years of combined expertise in modeling, analysis, and simulation methods from molecular modeling to clinical trial simulation, Certara supports translational science needs.
Certara is dedicated to improving human health by offering a broad spectrum of software products and services, with special focus on supporting translational approaches to drug development. Formed by uniting industry leaders Tripos and Pharsight, Certara leverages nearly 50 years of combined expertise in modeling, analysis, and simulation methods, from molecular modeling to clinical trial simulation, to help accelerate decision making in early drug discovery through clinical drug development, enabling cross-disciplinary approaches that eliminate bottlenecks and impediments to translational science.

At Certara, we understand that much of what the industry is seeking today in translational science is aimed at the movement and management of information. It’s about making information more accessible, sharing data across projects and across project teams, and bringing safety assessment of lead compounds into earlier stages of the drug development process - to better utilize corporate resources to improve the effectiveness of drug development. Certara is providing solutions in predictive science, communication, and informatics that facilitate bi-directional sharing of information, support communication between members of interdisciplinary research teams, and enable safety/tox assessments to be made earlier in the process, truly enabling translational science.
Search Our Archives